CClinicalTrials.gg
CompletedNCT02444195Updated Mar 20, 2017

Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

An interventional study of Guided Imagery With Audio Media in Uterine Cervical Neoplasms, Uterine Neoplasms and Ovarian Neoplasms, sponsored by University of Michigan. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-03-20.

Sponsored by University of Michigan · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this study is to evaluate the effectiveness of self-administered perioperative guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing surgical management for a presumed cancer diagnosis.

02

Conditions studied

  • Uterine Cervical Neoplasms
  • Uterine Neoplasms
  • Ovarian Neoplasms
  • Urogenital Neoplasms
  • Fallopian Tube Neoplasms

Keywords

  • gynecologic cancer
  • guided imagery
  • postoperative distress
  • perioperative distress
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 130 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Undergoing surgical management for a suspected diagnosis of Gynecologic Malignancy (Endometrial, Ovarian, Vulvar, Vaginal, Primary Peritoneal, Fallopian Tube)
  • Age 18 or greater
  • Receiving care at University of Michigan Comprehensive Cancer Center Gynecologic Oncology Clinic or at St. Joseph Mercy Hospital, Alexander Cancer Care Center
  • Able to understand and read English
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • Patients must have working telephone, mobile or land line

Exclusion criteria

Exclusion Criteria:

  • Severe hearing impairment that limits the ability to use audio-based guided imagery modules
  • Current documented alcohol abuse or illicit drug substance abuse
  • Planned outpatient surgery
  • Patients currently participating in a meditation practice for more than 1 hour per week prior to preoperative visit.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    Guided Imagery

    Guided Imagery With Audio Media

    Behavioral: Guided Imagery With Audio Media

  • No intervention
    Routine Postoperative Care

    Subjects will receive routine pre-operative, intra-operative, post-operative, chemotherapy, and radiation care as dictated by pathologic diagnosis.

Interventions

  • BehavioralGuided Imagery With Audio Media

    Subjects assigned to the experimental arm will be asked to participate in meditation daily using the audio media provided for the 7 days prior to surgery, in the preoperative holding area, for the 7 days following surgery, and are encouraged to engage in affirmations module use at least weekly in the 6-8 week postoperative period.

06

What researchers measure

Primary outcomes

  1. Level of distress in the immediate postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument.

    Time frame: postoperative day 1

  2. Level of distress in the delayed postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument.

    Time frame: 6-8 week postoperative exam

Secondary outcomes

  1. Level of distress, measured by questionnaire using the Hospital Anxiety and Depression Scale-total (HADS-T).

    Time frame: postoperative day 1 and 6-8 week postoperative exam

  2. Level of anxiety and depressions, measured by questionnaire using the Hospital Anxiety and Depression Scale subscale for anxiety (HADS-A) and depression (HADS-D).

    Time frame: postoperative day 1 and 6-8 week postoperative exam

  3. Level of pain, measured by a 7-item questionnaire using a Likert numerical rating scale for pain

    Time frame: postoperative day 1 and 6-8 week postoperative exam

  4. Perioperative analgesic use, measured by patient-completed usage log and hospital medical record.

    Time frame: postoperative day 1 and 6-8 week postoperative exam

  5. Patient satisfaction regarding in hospital perioperative care, measured by a questionnaire adapted from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey.

    Time frame: postoperative day 1 and 6-8 week postoperative exam

  6. Effect of perioperative guided imagery on health care compliance, measured by the General Adherence Scale (GAS) survey.

    Time frame: 6-8 week postoperative visit

  7. Effect of perioperative guided imagery on health care related locus of control, measured by the Multidimensional Health Locus of Control-form A (MHLC-A) questionnaire.

    Time frame: postoperative day 1 and 6-8 week postoperative exam

  8. The effect of perioperative guided imagery on hope, measured by the Adult Hope Scale (AHS) questionnaire.

    Time frame: postoperative day 1 and 6-8 week postoperative exam

07

Study locations

1 site
  • University of Michigan Cancer Center
    Ann Arbor, Michigan 48109, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02444195
Lead sponsor
University of Michigan
Responsible party
Brandy Michaels (Gynecologic Oncology Fellow, University of Michigan) — Principal investigator
First posted
May 14, 2015
Start date
Apr 2015
Primary completion
May 1, 2016
Completion
May 1, 2016
Last update
Mar 20, 2017

Study contacts

Brandy Michaels, MD
principal investigator · University of Michigan
J. Rebecca Liu, MD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion